Eastland Medical Systems

Eastland Medical Systems was an Australian-based healthcare company that focused on the development and commercialization of medical devices and specialty pharmaceuticals. The company's flagship products included the Clip-Lock Safety Syringe, a proprietary technology designed to prevent needle-stick injuries among healthcare workers. Additionally, Eastland developed Arsumax, a sublingual formulation of artesunate intended for the rapid treatment of malaria, particularly in pediatric patients in sub-Saharan Africa. Despite achieving regulatory milestones and establishing international distribution partnerships, the company faced significant capital constraints. Eastland Medical Systems was ultimately delisted from the Australian Securities Exchange in 2013. Its efforts were primarily directed toward improving healthcare delivery in resource-limited settings through innovative drug delivery platforms.